Keywords
Pathophysiology
Neurological manifestations
Categories
How to Cite
Abstract
At the end of last year, the occurrence of pneumonia of unknown etiology was reported, subsequently confirming that it was caused by a new coronavirus called SARS-CoV-2. The COVID-19 outbreak was declared a pandemic, and currently, the disease affected more than 4 million persons and caused thousands of deaths around the world. In our country the number of infected amounts to more than 10,000 and more than 400 deaths have occurred. Within the spectrum of clinical manifestations, the neurological ones have been gaining relevance in the last reports, some association (unconfirmed) with strokes and Guillain-Barré syndrome has even been proposed. In this review we intend to collect the available information on the pathophysiology and neurological manifestations of SARS-CoV-2.
References
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
Coronavirus disease (COVID-19) Pandemic. World Health Organization, Geneva, mayo 2, 2020. Disponible en: https://www.who.int/ emergencies/diseases/novel-coronavirus-2019. (Consulta: 2 de mayo, 2020)
Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients. J Med Virol 2020; 92(6): 552-555. https://doi.org/10.1002/jmv.25728
Hamming I, Timens W, Bulthuis ML, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004; 203(2): 631-637. https://doi.org/10.1002/path.1570
To KF, Lo AW. Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2). J Pathol 2004; 203(3): 740-743. https://doi.org/10.1002/path.1597
Li K, Wohlford-Lenane C, Perlman S, et al. Middle east respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J Infect Dis 2016; 213(5): 712-722. https://doi.org/10.1093/infdis/jiv499
Netland J, Meyerholz DK, Moore S, et al. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 2008; 82(15): 7264-7275. https://doi.org/10.1128/JVI.00737-08
Matsuda K, Park CH, Sunden Y, et al. The vagus nerve is one route of transneural invasion for intranasally inoculated influenza a virus in mice. Vet Pathol 2004; 41(2): 101-107. https://doi.org/10.1354/vp.41-2-101
Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 2020; S0889-1591 (20) 30357-3. https://doi.org/10.1016/j.bbi.2020.03.031
Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: A systematic review. J Neurol Sci 2020; 413: 116832. https://doi.org/10.1016/j.jns.2020.116832
Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia: an official clinical practice guideline of the American Thoracic Society and Infectious Disease Society of America. Am J Respir Crit Care Med 2019; 200(7): e45-e67. https://doi.org/10. 1164/rccm.201908-1581ST.
Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; e201127. https://doi.org/10.1001/jamaneurol.2020.1127
Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020; 382(23): 2268.2270. https://doi.org/10.1056/NEJMc2008597
Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 2020; 94: 55-58. https://doi.org/10.1016/j.ijid.2020.03.062.
Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8(4): 420-422. https://doi.org/10.1016/S2213-2600(20)30076-X
Li Y, Wang M, Zhou Y, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study (3/3/2020). Disponible en: https://ssrn.com/ abstract¼3550025. (Consulta: 3 de mayo, 2020).
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395(10229): 1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3
Kwee RM, Krdzalic J, Fasen BACM, et al. CT scanning in suspected stroke or head trauma: is it worth to go the extra mile and include the chest to screen for COVID-19 infection? Am J Neuroradiol 2020. https://doi.org/10.3174/ajnr.A6607
Padroni M, Mastrangelo V, Asioli GM, et al. Guillain-Barré syndrome following COVID-19: new infection, old complication? J Neurol 2020; 1-3. https://doi.org/10.1007/s00415-020-09849-6
Camdessanche JP, Morel J, Pozzetto B, et al. COVID-19 may induce Guillain-Barré syndrome. Rev Neurol (Paris) 2020; 176(6): 516-518. https://doi.org/10.1016/j.neurol.2020.04.003.
Alberti P, Beretta S, Piatti M, et al. Guillain-Barré syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm 2020; 7(4): e741. https://doi.org/10.1212/NXI.0000000000000741.
Otmani H, Moutawakil B, Rafai MA, et al. Covid-19 and Guillain-Barré syndrome: More than a coincidence! Rev Neurol (Paris) 2020; 176(6): 518-519. https://doi.org/10.1016/j.neurol.2020.04.007.
The magazine does not retain the reproduction rights (copyright) so the authors can republish their works with the sole mention of the original publication source.